<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Allergy Clin Immunol</journal-id><journal-id journal-id-type="iso-abbrev">J Allergy Clin Immunol</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>The Journal of allergy and clinical immunology</journal-title></journal-title-group><issn pub-type="ppub">0091-6749</issn><issn pub-type="epub">1097-6825</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10939859</article-id><article-id pub-id-type="pmcid-ver">PMC10939859.319</article-id><article-id pub-id-type="pmcaid">10939859</article-id><article-id pub-id-type="pmcaiid">10939859</article-id><article-id pub-id-type="manuscript-id">NIHMS1955327</article-id><article-id pub-id-type="pmid">38040042</article-id><article-id pub-id-type="doi">10.1016/j.jaci.2023.11.025</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1955327</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1955327</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>NSAID &#8220;allergy&#8221; labeling is associated with increased postpartum opioid utilization</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="L">Lily</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chang</surname><given-names initials="Y">Yuchiao</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Smith</surname><given-names initials="NA">Nicole A.</given-names></name><degrees>MD, MPH</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Losina</surname><given-names initials="E">Elena</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Costenbader</surname><given-names initials="KH">Karen H.</given-names></name><degrees>MD, MPH</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Laidlaw</surname><given-names initials="TM">Tanya M.</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women&#8217;s Hospital, Boston</aff><aff id="A2"><label>2</label>Harvard Medical School</aff><aff id="A3"><label>3</label>Division of General Internal Medicine, Massachusetts General Hospital, Boston</aff><aff id="A4"><label>4</label>Division of Maternal Fetal Medicine, Department of Obstetrics and. Gynecology, Brigham and Women&#8217;s Hospital, Boston</aff><aff id="A5"><label>5</label>Department of Orthopedic Surgery, Brigham and Women&#8217;s Hospital, Boston</aff><aff id="A6"><label>6</label>Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women&#8217;s Hospital, Boston</aff><author-notes><corresp id="CR1"><bold>Corresponding author:</bold> Lily Li, MD, Brigham and Women&#8217;s Hospital, Division of Allergy and Clinical Immunology, 60 Fenwood Road, 5002D, Boston, MA 02115, Telephone: 617-525-6332, <email>lli39@bwh.harvard.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>3</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>30</day><month>11</month><year>2023</year></pub-date><volume>153</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">457840</issue-id><fpage>772</fpage><lpage>779.e4</lpage><pub-history><event event-type="nihms-submitted"><date><day>01</day><month>01</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>01</day><month>03</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>01</day><month>03</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-03-01 00:25:24.073"><day>01</day><month>03</month><year>2025</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1955327.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P1">Current guidelines recommend a stepwise approach to postpartum pain management, beginning with acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and with opioids added only if needed. Report of a prior NSAID-induced adverse drug reaction (ADR) may preclude use of first-line analgesics, despite evidence that many patients with this allergy label may safely tolerate NSAIDs.</p></sec><sec id="S2"><title>Objective:</title><p id="P2">To assess the association between reported NSAID ADRs and postpartum opioid utilization.</p></sec><sec id="S3"><title>Methods:</title><p id="P3">We performed a retrospective cohort study of birthing people who delivered within an integrated health system (1/1/2017&#8211;12/31/2020). Study outcomes were postpartum inpatient opioid administrations and opioid prescriptions at discharge. Statistical analysis was performed on a propensity score-matched sample, which was generated with the goal of matching to the covariate distributions from individuals with NSAID ADRs.</p></sec><sec id="S4"><title>Results:</title><p id="P4">Of 38,927 eligible participants, there were 883 (2.3%) with an NSAID ADR. Among individuals with reported NSAID ADRs, 49.5% received inpatient opioids in the postpartum period, compared with 34.5% of those with no NSAID ADRs (difference=15.0%, 95% CI [11.4&#8211;18.6%]). For patients who received postpartum inpatient opioids, those with NSAID ADRs received a higher total cumulative dose between delivery and hospital discharge (median 30.0 vs 22.5 morphine milligram equivalents [MME] for vaginal deliveries; median 104.4 vs 75.0 MME for cesarean deliveries). The overall proportion of patients receiving an opioid prescription at the time of hospital discharge was higher for patients with NSAID ADRs compared to patients with no NSAID ADRs (39.3% vs 27.2%, difference=12.1%, 95% CI [8.6&#8211;15.6%]).</p></sec><sec id="S5"><title>Conclusion:</title><p id="P5">Patients with reported NSAID ADRs had higher postpartum inpatient opioid utilization and more frequently received opioid prescriptions at hospital discharge compared to those without NSAID ADRs, regardless of mode of delivery.</p></sec></abstract><abstract id="ABS2" abstract-type="summary"><title>Capsule Summary:</title><p id="P6">In this cohort study, presence of NSAID ADR labeling was associated with increased inpatient opioid utilization in the immediate postpartum period, and higher rates of opioid prescribing at hospital discharge following delivery.</p></abstract><kwd-group><kwd>Aspirin</kwd><kwd>non-steroidal anti-inflammatory drug (NSAID)</kwd><kwd>hypersensitivity</kwd><kwd>drug allergy</kwd><kwd>adverse drug reaction</kwd><kwd>opioids</kwd><kwd>analgesics</kwd><kwd>pain</kwd><kwd>childbirth</kwd><kwd>post-partum</kwd><kwd>utilization</kwd><kwd>electronic health record</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>